Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.

Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 22 10 2020
medline: 22 10 2020
entrez: 21 10 2020
Statut: ppublish

Résumé

In the original publication of the article, the authors would like to alter the color of characters in the Supplemental Table 1 and 2.

Identifiants

DOI: 10.1007/s12185-020-03019-0 PMID: 33085031
pubmed: 33085031
doi: 10.1007/s12185-020-03019-0
pii: 10.1007/s12185-020-03019-0
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

906

Commentaires et corrections

Type : ErratumFor

Auteurs

Sachie Kasai (S)

Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Hidehiro Itonaga (H)

Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4, Sakamoto, Nagasaki city, Nagasaki, Japan. itonaga-ngs@umin.ac.jp.
ORCID: 0000-0003-1438-3623

Daisuke Niino (D)

Department of Pathology, Sasebo City General Hospital, Sasebo, Japan.

Hiroaki Miyoshi (H)

Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.

Takeharu Kato (T)

Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan.

Daisuke Imanishi (D)

Department of Hematology, Nagasaki Prefecture Gotochuoh Hospital, Goto, Japan.

Machiko Fujioka (M)

Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.

Takafumi Furumoto (T)

Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.

Shinya Sato (S)

Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.

Yasushi Sawayama (Y)

Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.

Jun Taguchi (J)

Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.

Yoshitaka Imaizumi (Y)

Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.

Tomoko Hata (T)

Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4, Sakamoto, Nagasaki city, Nagasaki, Japan.

Shinichiro Yoshida (S)

Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan.

Yukiyoshi Moriuchi (Y)

Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.

Koichi Ohshima (K)

Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.

Yasushi Miyazaki (Y)

Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4, Sakamoto, Nagasaki city, Nagasaki, Japan.
Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.

Classifications MeSH